Homestead Advisers’s Emergent Biosolutions EBS Stock Holding History

Homestead Advisers’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-57,525	Closed	-$1.79M	–	136
2022 Q2	$1.79M	Hold	57,525	–	–	0.05%	100
2022 Q1	$2.36M	Hold	57,525	–	–	0.06%	100
2021 Q4	$2.5M	Hold	57,525	–	–	0.06%	101
2021 Q3	$2.88M	Buy	57,525 +1,600	+3%	+$96.9K	0.07%	97
2021 Q2	$3.52M	Hold	55,925	–	–	0.08%	93
2021 Q1	$5.2M	Sell	55,925 -2,700	-5%	-$277K	0.12%	75
2020 Q4	$5.25M	Sell	58,625 -4,500	-7%	-$413K	0.13%	73
2020 Q3	$6.52M	Sell	63,125 -6,500	-9%	-$701K	0.18%	64
2020 Q2	$5.51M	Sell	69,625 -700	-1%	-$52.2K	0.14%	64
2020 Q1	$4.07M	Sell	70,325 -1,720	-2%	-$99.1K	0.12%	70
2019 Q4	$3.89M	Sell	72,045 -64,299	-47%	-$3.49M	0.08%	84
2019 Q3	$7.13M	Buy	136,344 +16,234	+14%	+$756K	0.14%	93
2019 Q2	$5.8M	Buy	120,110 +4,676	+4%	+$224K	0.11%	99
2019 Q1	$5.83M	Buy	+115,434	New	+$6.81M	0.11%	87

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Homestead Advisers's EBS Position: Q3 2022 in Review

Homestead Advisers sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 57,525 shares — an estimated $1.79M sold.

Homestead Advisers first reported a position in EBS in Q1 2019 and held it in 14 quarters. The position peaked at $7.13M in Q3 2019. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

Homestead Advisers reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
Homestead Advisers sold 57,525 Emergent Biosolutions shares in Q3 2022, an estimated $1.79M.
Homestead Advisers first reported a position in Emergent Biosolutions in Q1 2019 and held it in 14 quarters.
Homestead Advisers's Emergent Biosolutions position peaked at $7.13M in Q3 2019.
211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Homestead Advisers's 13F filing for Q3 2022, filed 7 Nov 2022.